☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
baricitinib
Insights+: Breakthrough Therapy Designation by the US FDA in 2020
March 11, 2021
PharmaShots Interview: Eli Lilly's Dr. Lotus Mallbris Shares Insights on Baricitinib
October 12, 2020
Lilly's Olumiant (baricitinib) Receives CHMP's Positive Opinion for Moderate to Severe Atopic Dermatitis
September 21, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
